MERKEL CELL CARCINOMA OF SKIN
Clinical trials for MERKEL CELL CARCINOMA OF SKIN explained in plain language.
Never miss a new study
Get alerted when new MERKEL CELL CARCINOMA OF SKIN trials appear
Sign up with your email to follow new studies for MERKEL CELL CARCINOMA OF SKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental virus injection takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new treatment called VET3-TGI, a virus designed to infect and kill cancer cells. It is given alone or with an immunotherapy drug (atezolizumab) to about 60 adults with advanced solid tumors that have not responded to standard treatments. The main go…
Matched conditions: MERKEL CELL CARCINOMA OF SKIN
Phase: PHASE1 • Sponsor: KaliVir Immunotherapeutics • Aim: Disease control
Last updated May 26, 2026 06:11 UTC
-
New hope for advanced skin cancers: first human trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug called KUP-101A in 21 people with advanced skin cancers (like melanoma or Merkel cell carcinoma) that have not responded to standard treatments. The main goal is to find a safe dose and check for side effects. Researchers will also look at …
Matched conditions: MERKEL CELL CARCINOMA OF SKIN
Phase: PHASE1 • Sponsor: Kupando GmbH • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
Can a simple blood test predict skin cancer outcomes?
Knowledge-focused Recruiting nowThis study looks at blood samples from 20 people with melanoma or other skin cancers to see if certain markers in the blood can predict how well treatment works or how long patients live. Participants give blood during their regular care. The goal is to find better ways to monito…
Matched conditions: MERKEL CELL CARCINOMA OF SKIN
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
Scientists test immune cells against rare skin cancer in the lab
Knowledge-focused Recruiting nowThis study is testing a new cell therapy approach in the lab for people with Merkel cell carcinoma, a rare skin cancer linked to a virus. Researchers will take immune cells from 15 patients and see if they can be trained to attack the cancer in a test tube. The goal is to check i…
Matched conditions: MERKEL CELL CARCINOMA OF SKIN
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC